Sunshine Biopharma Inc. (SBFM)
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Last price
- $3.11
- As of
Kresmion compiles this page from SBFM's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Sunshine Biopharma Inc. (SBFM): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-14.
See the full SBFM dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for SBFM on one page. Preview it with sample data, then open it live with a free account.
Preview the SBFM dossierActive events for SBFM
- mediumEarnings below estimates
Q2-2025: Missed consensus by 247.6% - EPS $-3.9 vs $-1.122 estimate
- mediumEarnings below estimates
Q3-2025: Missed consensus by 43.3% - EPS $-1.9 vs $-1.326 estimate
- mediumEarnings below estimates
Q4-2025: Missed consensus by 96.1% - EPS $-5.4 vs $-2.754 estimate
- mediumEarnings below estimates
Missed consensus by 247.6% - EPS $-3.9 vs $-1.122 estimate
- mediumEarnings below estimates
Missed consensus by 43.3% - EPS $-1.9 vs $-1.326 estimate
FREE, NO ACCOUNT
Every event on SBFM, as it fires
You are seeing 5 of 9 events recorded on SBFM since 2026-05-31.
The five above all landed on 2026-06-19. The other 4 were recorded on 2 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, SBFM
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
SBFM against its peers
SBFM's operating margin of -17.2% ranks in the 68th percentile of 10 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2025-05-31 and 2026-06-30.
| Metric | SBFM | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 36.3M USD | 832593 USD | 95 | 10 |
| Revenue YoY | n/a | 3.9% | n/a | 6 |
| Gross margin | 33.8% | 35.0% | 50 | 10 |
| Operating margin | -17.2% | -145.9% | 68 | 10 |
| Net margin | -16.5% | -94.3% | 73 | 12 |
| Return on equity | -25.9% | -58.8% | 81 | 7 |
Peers (15): CBIH, CVSI, PRFX, BUDZ, LVRLF, IMCC, CPMD, YCBD, APUS, GELS, SKYI, SNOA, NPHC, INM, CBDY. Left out: PCYN (period gap), CANN (period gap), AKAN (period gap), CTTH (period gap), RDHL (period gap), NASC (period gap), PLSH (period gap), KAYS (period gap), SFWJ (no annual filing), CBDL (no annual filing). Fiscal periods ending between 2025-05-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (SBFM: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow SBFM on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to SBFM for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.